Nitric oxide synthase genes and their interactions with environmental factors in Parkinson's disease

被引:86
|
作者
Hancock, Dana B. [1 ]
Martin, Eden R. [2 ]
Vance, Jeffery M. [2 ]
Scott, William K. [2 ]
机构
[1] Duke Univ, Univ Program Genet & Genom, Durham, NC 27710 USA
[2] Univ Miami, Miller Sch Med, Miami Inst Human Genom, Miami, FL 33136 USA
基金
美国国家卫生研究院;
关键词
Parkinson disease; nitric oxide synthase; case-control studies; risk factors;
D O I
10.1007/s10048-008-0137-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Nitric oxide synthase (NOS) genes (NOS1, NOS2A, and NOS3) may create excess nitric oxide that contributes to neurodegeneration in Parkinson's disease (PD). NOS genes might also interact with one another or with environmental factors in PD. Coding and tagging single nucleotide polymorphisms (SNPs) (27 NOS1, 18 NOS2A, and five NOS3 SNPs) were genotyped in families with PD (1,065 cases and 1,180 relative and other controls) and were tested for allelic associations with PD using the association in the presence of linkage test and the pedigree disequilibrium test (PDT), allelic associations with age-at-onset (AAO) using the quantitative transmission disequilibrium test, and interactions using the multifactor dimensionality reduction-PDT. Gene-environment interactions involving cigarette smoking, caffeine, nonsteroidal anti-inflammatory drugs, and pesticides were examined using generalized estimating equations in participants with environmental data available. Significant associations with PD were detected for the NOS1 SNPs rs3782218, rs11068447, rs7295972, rs2293052, rs12829185, rs1047735, rs3741475, and rs2682826 (range of p=0.00083-0.046) and the NOS2A SNPs rs2072324, rs944725, rs12944039, rs2248814, rs2297516, rs1060826, and rs2255929 (range of p=0.0000040-0.047) in earlier-onset families with sporadic PD, and some SNPs were also associated with earlier AAO. There was no compelling statistical evidence for gene-gene interactions. However, of the significantly associated SNPs, interactions were found between pesticides and the NOS1 SNPs rs12829185, rs1047735, and rs2682826 (range of p=0.012-0.034) and between smoking and the NOS2A SNPs rs2248814 (p=0.021) and rs1060826 (p=0.013). These data implicate NOS1 and NOS2A as genetic risk factors for PD and demonstrate that their interactions with established environmental factors may modulate the environmental effects.
引用
收藏
页码:249 / 262
页数:14
相关论文
共 50 条
  • [21] Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson’s disease
    Yu Watanabe
    Hiroyuki Kato
    Tsutomu Araki
    Metabolic Brain Disease, 2008, 23 : 51 - 69
  • [22] The Effect of a Promoter Polymorphism on the Transcription of Nitric Oxide Synthase 1 and Its Relevance to Parkinson's Disease
    Rife, Terrie
    Rasoul, Bareza
    Pullen, Nicholas
    Mitchell, David
    Grathwol, Kristen
    Kurth, Janice
    JOURNAL OF NEUROSCIENCE RESEARCH, 2009, 87 (10) : 2319 - 2325
  • [23] 5′-Flanking region polymorphism of the neuronal nitric oxide synthase gene with Parkinson's disease in Taiwan
    Lo, HS
    Hogan, EL
    Soong, BW
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 194 (01) : 11 - 13
  • [24] Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease
    Watanabe, Yu
    Kato, Hiroyuki
    Araki, Tsutomu
    METABOLIC BRAIN DISEASE, 2008, 23 (01) : 51 - 69
  • [25] Effect of neuronal nitric oxide synthase inhibitors and antioxidants in an experimental model of Parkinson's disease in the rat
    Hicks, CA
    Murray, TK
    Swettenham, JB
    Dell, CP
    O'Neill, MJ
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 113 - 113
  • [26] Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis
    Beal, MF
    ANNALS OF NEUROLOGY, 1998, 44 (03) : S110 - S114
  • [27] Serum nitric oxide, lipid hydroperoxide levels, nitric oxide synthase activity and total serum antioxidant capacity in patients with Parkinson's disease
    Cubukcu, H. C.
    Yurtdas, M.
    Durak, Z. E.
    Aytac, B.
    Gunes, H. N.
    Cokal, B. G.
    Yoldas, T. K.
    Durak, I.
    FEBS JOURNAL, 2016, 283 : 72 - 72
  • [28] Environmental risk factors in Parkinson's disease
    Kuopio, AM
    Marttila, RJ
    Helenius, H
    Rinne, UK
    MOVEMENT DISORDERS, 1999, 14 (06) : 928 - 939
  • [29] Genetic and environmental factors of Parkinson's disease
    Broussolle, E
    Thobois, S
    REVUE NEUROLOGIQUE, 2002, 158 : S11 - S23
  • [30] Nitric oxide, nitric oxide synthase, and hypertensive vascular disease
    Busse R.
    Fleming I.
    Current Hypertension Reports, 1999, 1 (1) : 88 - 95